Reach out to Included Health who can help you create an account with eMed and start the program screening process.

The program leverages both SMS/text and email communications for all program updates. It is recommended to remain opted into receiving SMS communications.

Once you receive your GLP-1 Weight Management Screening Kit, you have 30 days to submit your health profile and return your blood sample. If you do not return your kit within 30 days of receipt, you may be charged for the kit by your employer. eMed Live Virtual Proctors are available 24/7 365 days a week to guide you through the completion of your health profile.

eMed Live Virtual Proctors help you through your health profile quickly by offering non-clinical guidance, support, and instruction through the blood collection process. They also help you with medication adherence during weekly check-ins. We act as an expert accountability partner in your journey.

Simply log back in and you can pick up right where you left off.

Use your smart phone to scan the QR code on your GLP-1 Weight Management Screening Kit. It is recommended to always use a smartphone to access the portal because we leverage both the front and back camera on your phone to collect information.

A clinician will review your health profile and lab report. If the clinician has any questions, they will message you via the messaging portal in the web application. Otherwise, you will receive a notification of your assessment in the messaging portal.

All colleagues must use the GLP-1 Weight Management Screening Kit to generate a lab report. eMed currently does not support uploading existing lab reports.

Typically eligibility status will be communicated to colleagues within three business days of lab results and health profile being received by a clinician. Please keep an eye out for communications from clinicians if there are any follow-up questions about your health profile.

Typically, eligible colleagues within an organization’s program are able to be rescreened for eligibility annually. You can contact eMed customer support at (800) 730-2797 or support@emed.com if you have questions about why you were not approved.

eMed partners with a network of licensed clinicians who can prescribe medication, provide clinical consultation, and monitor patients in all 50 states. eMed is not a medical provider.

During the program, a clinician will determine and prescribe which GLP-1 medication is right for you. Further questions about medication can be discussed directly with the clinician.

Several GLP-1 medications were approved by the U.S. Food and Drug Administration (FDA) starting in 2005. These medications went through rigorous testing in clinical trials to evaluate their safety and efficacy before receiving FDA approval. Colleagues in the program will only receive medications approved by the FDA for weight management.

Program participation includes:

• • Initial at-home blood collection kit for screening
• • Prescription for GLP-1 medication, if eligible
• • 24/7 side effect support- no appointments needed
• • Annual blood work
• • Clinical consultations 
• • Medication refill visits 
• • Weekly check-ins with an eMed Live Virtual Proctor
• • Progress portal with results tracking
• • 24/7 customer support
  

The eMed GLP-1 Weight Management Program is a program offered through organizations to their eligible colleagues. Subscriptions provided by organizations are required. If you have any of the following, you will not be eligible:

• • Have a BMI under 27 
• • Currently pregnant, possibly pregnant, or actively trying to become pregnant
• • Breastfeeding or bottle-feeding with breastmilk
• • End-stage kidney disease (on or about to be on dialysis)
• • End-stage liver disease (cirrhosis)
• • Current or prior eating disorder (anorexia/bulimia)
• • Cancer (active diagnosis or treatment)
• • History of organ transplant on anti-rejection medication
• • Severe gastrointestinal condition (gastroparesis, inflammatory bowel disease)
• • History of or current pancreatitis
• • Type 1 diabetes
• • Type 2 diabetes on insulin
• • Diabetic retinopathy (eye condition related to diabetes)
• • Personal or family history of thyroid cyst/nodule, thyroid cancer, medullary thyroid carcinoma, or multiple endocrine neoplasia syndrome type 2
• • Deemed clinically ineligible for any other reason

Medication adherence is almost as important as the medication itself*. Weekly check-ins ensure you are on track by taking your medication at the right time and day each week, track your progress, as well as capture the information necessary to make sure you are prescribed the correct dosage each week.  *https://www.uspharmacist.com/article/medication-adherence-the-elephant-in-the-room

It is important to follow the tailored diet that will be designed for you. However, some general diet and lifestyle changes that might be suggested include:

• • Balanced Diet: It's important to follow a balanced diet that's low in refined sugars/processed foods and rich in whole foods. This can help manage blood sugar levels and minimize glucose fluctuations.
• • Food Color Counts: Fuel up and manage this disease with a variety of colorful, nutrient-dense foods. Enjoy a rainbow of fruits and veggies—dark leafy greens, blueberries, oranges, tomatoes—rich in vitamins, fiber, and minerals. Pair with whole grains and protein, like brown rice with salmon, for a nutritional boost!
• • Carbohydrate Awareness: Being aware of carbohydrate intake can help to manage post-meal blood sugar spikes. This doesn't mean avoiding carbohydrates entirely but rather choosing complex carbs and being mindful of portion sizes.
• • Regular Physical Activity: Exercise helps improve insulin sensitivity and can also contribute to weight loss. For overall health, adults need at least 150 minutes a week of moderate-intensity aerobic activity. This could be brisk walking 22 minutes a day; 30 minutes a day, 5 days a week; or what works for your schedule. Alternatively, you could do 75 minutes of vigorous-intensity aerobic activity each week, such as swimming laps. Or you could do an equivalent combination of moderate- and vigorous-intensity aerobic activity each week. Adults also need at least 2 days a week of muscle-strengthening activity. (CDC)
• • Limit Alcohol: Some GLP-1 medications may increase the risk of pancreatitis. Alcohol is also a known risk factor for pancreatitis, so avoiding or limiting alcohol consumption can be a wise precaution.
• • Stay Hydrated: Some GLP-1 medications can lead to dehydration, especially in the beginning. Drinking adequate water and monitoring for signs of dehydration can be important.‍
• • Limiting Fatty Foods: Some people experience gastrointestinal side effects when they consume large amounts of fatty foods while on GLP-1 medications. It might be helpful to limit the intake of such foods.

This information available through this portal provides general information about potential lifestyle changes for participants taking GLP-1 medications and is based on input from affiliated licensed clinicians. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider for personalized guidance regarding your health.

You can report side effects during each weekly check-in, or any time in the portal to receive support. Side effect support is available 24/7. If you are experiencing severe side effects, please stop this product and immediately visit an emergency room.

If you miss a weekly check-in, you will receive reminder communications to complete it within a certain time frame. Please follow your medication’s manufacturer's instructions on the exact time frame that you can take your medication after missing the day. It is important to note that any time you join a weekly check-in at a new day of week, your default day of week for check-ins will reset to this day.

During every third weekly check-in, you will be asked to complete a short refill questionnaire that will be sent for clinical review, along with the data captured during your weekly check-ins, to issue a new 30 day prescription. As you are progressing, your prescribed dose will likely gradually increase. This is usually every four weeks until you reach your maintenance dose.

Colleagues are required to complete at least 75% of their weekly check-ins on a rolling three month basis to remain in the program. Completing a check-in too far after your current week’s check-in, can result in not being adherent for the current week.

Colleagues need to submit their refill questionnaire to be sent for clinical review to get access to the program again.

eMed is committed to protecting your privacy, and we will not sell your data. Please see our Privacy Policy to understand the type of information we collect and the specific practices and guidelines that we employ to protect the security and confidentiality of your personal information.

eMed is online 24/7/365 no appointment necessary for support. Our eMed Live Virtual Proctors are trained to serve you at any time.

To delete your account, please contact our customer service team by sending an email to support@emed.com or calling us at 1-866-955-1173.Important: Once your account deletion is processed, it is permanent and cannot be undone.